Alphatec Holdings, Inc. ATEC

Set alert

Price alert · ATEC

All alert types
7.31 USD +0.27 +3.84%

At close · Nov 2

7.31 0.00 -0.05%

After hours · Nov 2, 6:16 PM ET

Bid
7.31 × 3
Ask
7.32 × 2
7.17 Day range 7.76
6.81 52-week range 23.29
YTD
-65.26%
1 year
-61.51%
Open
7.21
Prev close
7.04
Mkt cap
1.12B
Vol
14.20M
Avg vol
2.80M
EPS
-0.57
P/E
0.00
Div yield
0.00%
More statistics
Low
7.17
High
7.76
Forward P/E
12.80
Beta
0.87
Short ratio
6.04
Inst. own
75.47%
Dividend
0.00
Ex-div date
Earnings
Feb 23, 2027
50-d avg
10.14
200-d avg
10.56
1y target
14.18

YTD chart

Chart tools
Interval

Events in this range
  • Feb 24, 2026Earnings: 0.06; estimate 0.04; surprise 50%
  • May 5, 2026Earnings: -0.22; estimate -0.01; surprise -2100%
  • Aug 4, 2026Earnings: 0.07; estimate 0.06946; surprise 0.78%
  • Aug 5, 2026Rating: UBS · Buy → Buy
  • Oct 29, 2026Earnings: 0.09; estimate 0.09512; surprise -5.38%
  • Oct 30, 2026Rating: Needham · Buy → Buy
  • Oct 30, 2026Rating: Wells Fargo · Overweight → Overweight
  • Oct 30, 2026Rating: TD Cowen · Buy → Buy
  • Oct 30, 2026Rating: JP Morgan · Overweight → Overweight
  • Oct 30, 2026Rating: Canaccord Genuity · Buy → Buy
Signals (43)
NameDateAgo
SMA: BearishOct 30, 20263 days ago
SMA: BearishOct 30, 20263 days ago
MACD: Sell SignalOct 30, 20263 days ago
RSI: OversoldOct 30, 20263 days ago
SMA: BullishOct 22, 20261 week ago
MACD: Buy SignalOct 22, 20261 week ago
MACD: Sell SignalOct 16, 20262 weeks ago
SMA: BearishOct 13, 20262 weeks ago
SMA: BullishOct 12, 20263 weeks ago
MACD: Buy SignalOct 9, 20263 weeks ago
MACD: Sell SignalOct 7, 20263 weeks ago
MACD: Buy SignalOct 5, 20264 weeks ago
MACD: Sell SignalSep 24, 20261 month ago
SMA: BullishSep 11, 20261 month ago
MACD: Buy SignalSep 11, 20261 month ago
SMA: BearishSep 8, 20261 month ago
SMA: BullishSep 3, 20262 months ago
SMA: BearishSep 1, 20262 months ago
MACD: Sell SignalAug 17, 20262 months ago
MACD: Buy SignalJul 29, 20263 months ago
SMA: BullishJul 27, 20263 months ago
SMA: BearishJul 20, 20263 months ago
MACD: Sell SignalJul 17, 20263 months ago
SMA: BullishJun 25, 20264 months ago
MACD: Buy SignalMay 19, 20265 months ago
MACD: Sell SignalMay 6, 20266 months ago
RSI: OversoldMay 6, 20266 months ago
MACD: Buy SignalMay 4, 20266 months ago
MACD: Sell SignalApr 28, 20266 months ago
MACD: Buy SignalApr 8, 20266 months ago
RSI: OversoldMar 27, 20267 months ago
MACD: Sell SignalMar 26, 20267 months ago
RSI: OversoldMar 6, 20268 months ago
RSI: OversoldFeb 20, 20268 months ago
MACD: Buy SignalFeb 13, 20268 months ago
RSI: OversoldFeb 11, 20268 months ago
SMA: BearishJan 29, 20269 months ago
RSI: OversoldJan 27, 20269 months ago
RSI: OversoldJan 13, 20269 months ago
SMA: BearishJan 12, 20269 months ago
MACD: Sell SignalJan 12, 20269 months ago
RSI: OverboughtJan 8, 20269 months ago
MACD: Buy SignalJan 6, 202610 months ago

Key statistics

Market cap
1.12B
Enterprise value
1.63B
Trailing P/E
0.00
Forward P/E
12.80
PEG ratio
0.48
Price / sales
1.33
Price / book
0.00
EPS (TTM)
-0.57
Beta
0.87
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-10.35%
Revenue (TTM)
839.72M
Revenue growth
12.60%
Free cash flow
29.95M
Total cash
79.94M
Total debt
593.95M
Return on equity
-308.06%
Shares outstanding
153.33M
Short % of float
10.00%
50-day average
10.14
200-day average
10.56

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 14.18 +94.0% upside
Target (low)
8.00
Target (mean)
14.18
Target (high)
24.00
Ratings (0m) 14 13 buy · 1 hold · 0 sell
  • Strong buy3
  • Buy10
  • Hold1
  • Sell0
  • Strong sell0

Next earnings

Feb 23, 2027

Expected Feb 23, 2027. Consensus EPS estimate 0.12888.

Earnings history

Financials — quick view

All financials
ATEC Revenue — quarterly 221.17M
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
ATEC Net income — quarterly -5.47M
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
ATEC EPS — quarterly -0.03
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026

Earnings

ATEC recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 23, 2027Dec 30, 20260.18———
Oct 29, 2026Sep 30, 20260.095120.09-0.01-5.38%
Aug 4, 2026Jun 30, 20260.069460.070.00+0.78%
May 5, 2026Mar 31, 2026-0.01-0.22-0.21-2,100.00%
Feb 24, 2026Dec 31, 20250.040.06+0.02+50.00%
Oct 30, 2025Sep 30, 2025-0.030.03+0.06+200.00%

Upgrades / downgrades

ATEC analyst upgrades and downgrades
DateFirmActionFromTo
Oct 30, 2026Canaccord GenuitymainBuyBuy
Oct 30, 2026JP MorganmainOverweightOverweight
Oct 30, 2026TD CowenmainBuyBuy
Oct 30, 2026Wells FargomainOverweightOverweight
Oct 30, 2026NeedhammainBuyBuy
Aug 5, 2026UBSmainBuyBuy

About Alphatec Holdings, Inc.

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants, instruments, imaging equipment, and spare parts. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissue; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. The company was founded in 1990 and is headquartered in Carlsbad, California.

Sector
Healthcare
Industry
Medical Devices
Country
United States

News

Your note

Sign in to keep a note on ATEC — it syncs with the Stock Master app.

Insider holders

ATEC insider holders
InsiderRelationLatest transactionDateShares held
BERKOWITZ MORTIMERIIIDirectorStock Award(Grant)Jun 9, 20261,261,160
HUNSAKER CRAIG EOfficerStock GiftMar 8, 20261,725,610
LISH SCOTTChief Operating OfficerSaleMar 12, 2026815,704
MARSHALL TYSON ELIOTGeneral CounselSaleAug 4, 2026630,398
MILES PATRICK SChief Executive OfficerPurchaseSep 9, 20266,154,450
PELIZZON DAVID RDirectorStock Award(Grant)Jun 9, 202610,773,900

Institution ownership

ATEC institution ownership
Holder% heldSharesValueReported
Blackrock Inc.7.30%11,326,67782.80MJun 29, 2026
Braidwell LP 4.21%6,531,43947.74MJun 29, 2026
American Century Companies Inc4.20%6,521,65947.67MJun 29, 2026
Vanguard Capital Management LLC3.30%5,122,68137.45MJun 29, 2026
BNP Paribas Asset Management Holding S.A.2.28%3,536,53825.85MJun 29, 2026
State Street Corporation2.24%3,481,34925.45MJun 29, 2026

Fund ownership

ATEC fund ownership
Holder% heldSharesValueReported
American Century Mutual Funds, Inc.-Small Cap Growth Fund3.16%4,902,02835.83MJul 30, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.35%3,649,92526.68MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF2.06%3,198,45523.38MSep 29, 2026
VANGUARD WHITEHALL FUNDS-Vanguard Mid-Cap Growth Fund1.42%2,196,27416.05MJul 30, 2026
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund0.87%1,345,3079.83MJun 29, 2026
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund0.87%1,351,6389.88MJul 30, 2026